Sareum Holdings (FRA:RYH0) ROCE %: -205.84% (As of Dec. 2025)


FRA:RYH0 Sareum Holdings PLC FRA:RYH0
32 GF Score
Price €0.21
! 3 Warning Signs
View Full Analysis

What is Sareum Holdings ROCE %?

Sareum Holdings FRA:RYH0 -4.63% 32 ROCE % is -205.84% as of Dec. 2025. GuruFocus rates FRA:RYH0 with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sareum Holdings's annualized ROCE % for the quarter that ended in Dec. 2025 was -205.84%.

Sareum Holdings  (FRA:RYH0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sareum Holdings ROCE % Related Terms

Sareum Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Sareum Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sareum Holdings ROCE % Chart

Sareum Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.48 -72.35 -147.67 -281.42 -153.72

Sareum Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -384.96 -228.72 -84.14 -121.17 -205.84
FRA:RYH0
32GF Score
Sareum Holdings PLC FRA:RYH0
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sareum Holdings ROCE % Calculation

Sareum Holdings's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-3.979/( ( (3.27 - 0.772) + (4.976 - 2.297) )/ 2 )
=-3.979/( (2.498+2.679)/ 2 )
=-3.979/2.5885
=-153.72 %

Sareum Holdings's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-4.162/( ( (4.976 - 2.297) + (3.698 - 2.333) )/ 2 )
=-4.162/( ( 2.679 + 1.365 )/ 2 )
=-4.162/2.022
=-205.84 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -205.84% mean?
Sareum Holdings (FRA:RYH0) has a ROCE % of -205.84% as of Dec. 2025.
Is Sareum Holdings' ROCE % too high?
Sareum Holdings' current ROCE % is -205.84%. Overall, Sareum Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sareum Holdings' ROCE % compare to VRTX and REGN?
Sareum Holdings' ROCE % of -205.84% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Sareum Holdings's current ROCE % is -205.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sareum Holdings stock overvalued right now?
Sareum Holdings (FRA:RYH0) has a current ROCE % of -205.84%. The current ROCE % is -205.84%. Sareum Holdings' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sareum Holdings (FRA:RYH0), the current ROCE % is -205.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sareum Holdings Business Description

Other Exchanges SAR:UK
Address Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
32GF Score

Get the complete analysis for FRA:RYH0

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price